 |
인쇄하기
취소
|
KFDA approves 9 clinical trials
The Korea Food and Drug Administration said it gave a green light for clinical trials for nine drugs, including Daehwa's anticancer agent DHP107 (paclitaxel) and GlaxoSmithKline's Tykerb (lapatinib).
Tykerb, an experimental drug, helps stall advanced breast cancer. This medication, taken along with Xeloda, was shown to be twice as effective in slowing down an aggressive type of breast cancer...
Tykerb, an experimental drug, helps stall advanced breast cancer. This medication, taken along with Xeloda, was shown to be twice as effective in slowing down an aggressive type of breast cancer...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.